Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection

Neuroscience

Volumn 140, Issue 4, 2006, Pages 1157-1168

  Ruano, D ^a   Revilla, E ^a   Paz Gavilan M ^a   Vizuete, M L ^a   Pintado, C ^a   Vitorica, J ^a   Castano A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

caspase 11; cytokines; neurodegeneration; Parkinson; substantia nigra

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 11; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR; S METHYLPSEUDOTHIOUREA; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC NERVE CELL; ENCEPHALITIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ANIMALS; DOPAMINE; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; NERVE DEGENERATION; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 33745269269     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.073     Document Type: Article

References (56)

1. Arai H., Furuya T., Yasuda T., Miura M., Mizuno Y., and Mochizuki H. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. J Biol Chem 279 (2004) 51647-51653
2. Arimoto T., and Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol Dis 12 (2003) 35-45
3. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., and Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15 (1996) 1914-1923
4. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18 (1998) 1633-1641
5. Boje K.M., and Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587 (1992) 250-256
6. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., and Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172 (1994) 151-154
7. Brosnan C.F., Battistini L., Raine C.S., Dickson D.W., Casadevall A., and Lee S.C. Reactive nitrogen intermediates in human neuropathology. An overview. Dev Neurosci 16 (1994) 152-161
8. Castaño A., Herrera A.J., Cano J., and Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70 (1998) 1584-1592
9. Castaño A., Herrera A.J., Cano J., and Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem 81 (2002) 150-157
10. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., and Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149 (1992) 2736-2741
11. Chen C.C., and Wang J.K. p38 But not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 55 (1999) 481-488
12. Dawson V.L., Brahmbhatt H.P., Mong J.A., and Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 33 (1994) 1425-1430
13. de Bock F., Derijard B., Dornand J., Bockaert J., and Rondouin G. The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-alpha. Eur J Neurosci 10 (1998) 3107-3114
14. del Río J.C., Araujo F., Ramos B., Ruano D., and Vitorica J. Prevalence between different alpha subunits performing the benzodiazepine binding sites in native heterologous GABA(A) receptors containing the alpha2 subunit. J Neurochem 79 (2001) 183-191
15. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., and Brosnan C. Microglia and cytokines in neurological disease, with reference to AIDS and Alzheimer's disease. Glia 7 (1993) 75-83
16. Espey M.G., Chernyshev O.N., Reinhard Jr. J.F., Namboodiri M.A., and Colton C.A. Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 8 (1997) 431-434
17. Furuya T., Hayakawa H., Yamada M., Yoshimi K., Hisahara S., Miura M., Mizuno Y., and Mochizuki H. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 24 (2004) 1865-1872
18. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., and Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons. relevance to Parkinson's disease. J Neurochem 81 (2002) 1285-1297
19. Gayle D.A., Ling Z., Tong C., Landers T., Lipton J.W., and Carvey P.M. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture. roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 133 (2002) 27-35
20. Han I.O., Kim K.W., Ryu J.H., and Kim W.K. p38 Mitogen-activated protein kinase mediates lipopolysaccharide, not interferon-gamma, -induced inducible nitric oxide synthase expression in mouse BV2 microglial cells. Neurosci Lett 325 (2002) 9-12
21. Hartmann A., Hunot S., and Hirsch E.C. Inflammation and dopaminergic neuronal loss in Parkinson's disease. a complex matter. Exp Neurol 184 (2003) 561-564
22. Herrera A.J., Castaño A., Venero J.L., Cano J., and Machado A. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7 (2000) 429-447
23. Hirsch E.C., Breidert T., Rousselet E., Hunot S., Hartmann A., and Michel P.P. The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci 991 (2003) 214-228
24. Hisahara S., Yuan J., Momio T., Okano H., and Miura M. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 193 (2001) 111-122
25. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., and Hirsch E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19 (1999) 3440-3447
26. Hur J., Kim S.Y., Kim H., Cha S., Lee M.S., and Suk K. Induction of caspase-11 by inflammatory stimuli in rat astrocytes. lipopolysaccharide induction through p38 mitogen-activated protein kinase pathway. FEBS Lett 26 (2001) 157-162
27. Iravani M.M., Kashefi K., Mander P., Rose S., and Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110 (2002) 49-58
28. Iravani M.M., Leung C.C., Sadeghian M., Haddon C.O., Rose S., and Jenner P. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur J Neurosci 22 2 (2005) 317-330
29. Jeohn G.H., Cooper C.L., Wilson B., Chang R.C., Jang K.J., Kim H.C., Liu B., and Hong J.S. p38 MAP kinase is involved in lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures. Ann N Y Acad Sci 62 (2002) 332-346
30. Kang S.J., Wang S., Hara H., Peterson E.P., Namura S., Amin-Hanjani S., Huang Z., Srinivasan A., Tomaselli K.J., Thornberry N.A., Moskowitz M.A., and Yuan J. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 149 (2000) 613-622
31. Kang S.J., Wang S., Kuida K., and Yuan J. Distinct downstream pathways of caspase-11 in regulating apoptosis and cytokine maturation during septic shock response. Cell Death Differ 9 (2002) 1115-1125
32. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., and Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain. role of microglia. J Neurosci 20 (2000) 6309-6316
33. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., and Baik E.J. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J Neurosci Res 70 (2002) 97-107
34. Kong L.Y., McMillian M.K., Maronpot R., and Hong J.S. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Res 729 (1996) 102-109
35. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., and Berman J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150 7 (1993) 2659-2667
36. Liu B., Du L., and Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293 (2000) 607-617
37. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases. mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304 (2003) 1-7
38. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
39. Matsuo M., Hamasaki Y., Fujiyama F., and Miyazaki S. Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res 685 (1995) 201-204
40. McCallum S.E., Parameswaran N., Perez X.A., Bao S., McIntosh J.M., Grady S.R., and Quik M. Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates. J Neurochem 96 (2006) 960-972
41. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
42. Minghetti L., and Levi G. Microglia as effector cells in brain damage and repair. focus on prostanoids and nitric oxide. Prog Neurobiol 54 (1998) 99-125
43. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., and Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 211 (1996) 13-16
44. Monteiro H.P., Silva E.F., and Stern A. Nitric oxide. a potential inducer of adhesion-related apoptosis-anoikis. Nitric Oxide 10 1 (2004) 1-10
45. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6 12 (1992) 3051-3064
46. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376 (1995) 37-43
47. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic, Orlando, FL
48. Possel H., Noack H., Putzke J., Wolf G., and Sies H. Selective up-regulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia. in vitro and in vivo studies. Glia 32 (2000) 51-59
49. Ruano D., Araujo F., Revilla E., Vela J., Bergis O., and Vitorica J. GABA(A) and alpha-amino-3-hydroxy-5-methylsoxazole-4-propionate receptors are differentially affected by aging in the rat hippocampus. J Biol Chem 275 (2000) 19585-19593
50. Southan G.J., Szabo C., and Thiemermann C. Isothioureas. potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114 (1995) 510-516
51. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., and Dixit V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81 (1995) 801-809
52. Vela J., Vitorica J., and Ruano D. Rapid PCR-mediated synthesis of competitor molecules for accurate quantification of beta2 GABA(A) receptor subunit mRNA. Brain Res Protoc 8 (2001) 184-190
53. Vela J., Gutierrez A., Vitorica J., and Ruano D. Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J Neurochem 85 (2003) 368-377
54. Wang J.Y., Shum A.Y., Ho Y.J., and Wang J.Y. Oxidative neurotoxicity in rat cerebral cortex neurons. synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J Neurosci Res 72 (2003) 508-519
55. White J.A., Manelli A.M., Holmberg K.H., Van Eldik L.J., and LaDu M.J. Differential effects of oligomeric and fibrillar amyloid-β1-42 on astrocyte-mediated inflammation. Neurobiol Dis 18 (2005) 459-465
56. Zhao M., Momma S., Delfani K., Carlen M., Cassidy R.M., Johansson C.B., Brismar H., Shupliakov O., Frisen J., and Janson A.M. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 100 (2003) 7925-7930